Shares of GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $27.75 and traded as low as $25.08. GENMAB A/S/S shares last traded at $25.15, with a volume of 236,621 shares trading hands.
GENMAB A/S/S Trading Up 1.0 %
The company’s fifty day moving average is $27.75 and its two-hundred day moving average is $28.97.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Further Reading
- Five stocks we like better than GENMAB A/S/S
- What is the Nikkei 225 index?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- How Investors Can Find the Best Cheap Dividend Stocks
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Investing In Automotive Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
